ArticleNorth American Spine Society journal2026
Impact of sarcopenia and multifidus atrophy on outcomes from minimally invasive decompression surgery for lumbar spinal stenosis.
Article in North American Spine Society journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical significance and future applications of standardized imaging parameters for assessing paraspinal muscle fatty infiltration in lumbar degenerative disease: a narrative review.Journal of orthopaedic surgery and research · 2026Review
- Is bilateral laminectomy and fusion superior to total laminectomy and fusion in two-level lumbar spinal stenosis?Frontiers in surgery · 2026Article
- Effect of sarcopenia and paraspinal muscle morphology on conservative treatment outcomes in lumbar spinal stenosis: a prospective cohort study.Frontiers in aging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In order to improve outcomes for patients with lumbar spinal stenosis, identification of better prognostic factors is necessary to guide patient selection for surgery. The purpose of this study was to investigate the prognostic value of multifidus atrophy and sarcopenia on postoperative pain and disability following minimally invasive decompression for lumbar spinal stenosis. Methods: We retrospectively reviewed medical records and imaging studies for patients with lumbar spinal stenosis who underwent minimally invasive tubular decompression. Multifidus total cross sectional area (tCSA), multifidus functional cross sectional area (fnCSA), multifidus fatty infiltration (FI), psoas tCSA, and psoas relative cross sectional area (rCSA) were evaluated by univariable and multivariable regression to identify predictors of postoperative improvement in visual analogue scores for back pain (VASB) and leg pain (VASL) and Oswestry disability index (ODI) scores for disability. Results: Minimally invasive decompression was performed at 75 spinal levels in 64 patients with an average age of 70.1±10.0 years. In multivariable analysis, lower multifidus FI was significantly associated with 5 point improvement in ODI (p=.002), 10 point improvement in ODI (p=.017), and 17 point improvement in ODI (p=.044). Only male gender (p=.030), lower preoperative VASB (p=.001), and lower preoperative VASL (p=.015) were independently predictive of postoperative deterioration in ODI, VASB, and VASL, respectively. Conclusions: Multifidus FI predicts postoperative improvement in disability following minimally invasive decompression for lumbar spinal stenosis with high accuracy. Minimally invasive decompression surgery is effective for elderly patients and sarcopenic patients, who are not at risk for poorer postoperative outcomes. Male gender and lower preoperative pain or disability are risk factors for postoperative deterioration in patient-reported outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.